In this segment, the panelists explain that although there is currently no answer to what causes multiple sclerosis (MS), what has been learned can help providers treat MS patients more proactively.
Patricia K. Coyle, MD, says that ideas about the etiology of MS are evolving with genetics, environmental factors, and the host immune system, and discusses the recognized components that may be responsible for MS.
Dr Coyle explains that although inflammation plays a role, there may be a different type of inflammation driving the neuro-degenerative, more disabling phase of MS, compared with the typical relapsing, macroscopic lesions in the white matter phase.
Leslie Fish, PharmD, agrees with Dr Coyle and further explains her feelings about the correlation between inflammation and acute attacks.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More